WuHan Hvsen Biotechnology News

Huisheng Biotech: 2023 Internal Control Self-Evaluation Report

Apr 24 12:00 ET

Huisheng Biotech: Report on the 2023 Assessment of Accounting Firms Performance and the Audit Committee's Performance of Supervisory Duties

Apr 24 12:00 ET

Huisheng Biotech: Announcement on changing the registered capital and amending the “Articles of Association”

Apr 24 12:00 ET

Huisheng Biotech: Summary table on the use of non-operating capital and other related capital transactions in 2023

Apr 24 12:00 ET

Huisheng Biotech: Announcement on preparation for asset impairment in 2023

Apr 24 12:00 ET

Huisheng Biotech: Notice on Convening the 2023 Annual General Meeting of Shareholders

Apr 24 12:00 ET

Huisheng Biotech: Legal Opinion of Guohao Lawyer (Shenzhen) Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Wuhan Huisheng Biotechnology Co., Ltd.

Apr 19 06:38 ET

Huisheng Biotech: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Apr 19 06:38 ET

Huisheng Biotech: Notice on the fact that no regulatory measures or penalties have been taken by securities regulators or exchanges in the last five years

Apr 3 12:00 ET

Huisheng Biotech: Announcement on not revising the “Huisheng Convertible Bonds” conversion price downward

Apr 3 12:00 ET

Huisheng Biotech: Notice on requesting the shareholders' meeting to approve the exemption of controlling shareholders and their concerted actors from issuing takeover offers

Apr 3 12:00 ET

Huisheng Biotech: Announcement on the Change of Sponsors and Sponsor Representatives

Apr 3 12:00 ET

Huisheng Biotech: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024

Apr 3 12:00 ET

Huisheng Biotech: Announcement on signing share subscription agreements and related transactions with specific targets with entry into force

Apr 3 12:00 ET

Huisheng Biotech: Announcement on the subscription target issuing a letter of commitment not to reduce the company's stock holdings for a specific period

Apr 3 12:00 ET

Huisheng Biotech: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2024

Apr 1 03:39 ET

Huisheng Biotech: An indicative announcement on the conditions that Huisheng Convertible Bonds are expected to trigger a downward correction in the conversion price

Mar 27 03:54 ET

Huisheng Biotech: Legal Opinion of Guohao Lawyer (Shenzhen) Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Wuhan Huisheng Biotechnology Co., Ltd.

Mar 22 08:06 ET

Huisheng Biotech: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders

Mar 22 08:05 ET

Huisheng Biotech: Announcement on adding non-independent directors and independent directors to the 3rd board of directors

Mar 6 11:00 ET